Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_15-cv-02217/USCOURTS-caed-2_15-cv-02217-1/pdf.json

Parties Involved:
Jennifer Anzo
Plaintiff
Janssen Pharmaceuticals, Inc.
Defendant
Janssen Research & Development, LLC
Defendant
Johnson & Johnson
Defendant

Document Text:

CERTIFICATE OF SERVICE 

1195130.1 

Michael Brady Lynch (SBN 219214) 

Michael@mblynchfirm.com 

Amy E. German (SBN 105926) 

amy@mblynchfirm.com 

THE MICHAEL BRADY LYNCH FIRM

127 West Fairbanks Ave., Ste. 528 

Winter Park, FL 32789 

Telephone: (877) 513-9517 

Facsimile: (321) 972-3568 

Michael Louis Kelly (SBN 82063) 

mlk@kirtlandpackard.com 

Behram V. Parekh (SBN 180361) 

bvp@kirtlandpackard.com 

Ruth Rizkalla (SBN 224973) 

rr@kirtlandpackard.com 

KIRTLAND & PACKARD LLP 

2041 Rosecrans Avenue, Third Floor 

El Segundo, California 90245 

Telephone: (310) 536-1000 

Facsimile: (310) 536-1001 

Counsel for Plaintiff

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA 

JENNIFER ANZO, an individual; 

 Plaintiff, 

v. 

JANSSEN RESEARCH & DEVELOPMENT, 

LLC; JANSSEN PHARMACEUTICALS, INC.; 

JOHNSON & JOHNSON, 

 

 Defendants. 

CASE NO. 2:15-CV-02217-KJM-EFB 

STIPULATION AND ORDER TO STAY 

ACTION PENDING JPML DETERMINATION

WHEREAS, the Court's September 2, 2016 Minute Order provides that by the close of business 

Case 2:15-cv-02217-KJM-EFB Document 29 Filed 10/17/16 Page 1 of 3
CERTIFICATE OF SERVICE 

1195130.1 

on October 13, 2016, the parties shall file a stipulation/proposed order or Plaintiff shall file a motion for 

the filing of an amended complaint;

WHEREAS, the Parties agree Plaintiff filed her Complaint on October 26, 2015. Plaintiff 

alleges personal injuries resulting from use of Invokana. 

WHEREAS, the Parties agree that currently pending before the JPML is a Motion for Transfer 

of actions filed in this judicial district and other districts in the federal and state court system that 

involve Invokana use to be transferred to MDL 2750 for coordinated and consolidated pretrial 

proceedings, pursuant to 28 U.S.C. § 1407. 

WHEREAS, the Parties hereby stipulate that a stay is appropriate in the above-entitled action 

until after resolution of a pending motion before the Judicial Panel on Multidistrict Litigation 

(“JPML”) that seeks to transfer multiple cases filed against Defendant Janssen Pharmaceuticals, Inc., 

et al, (“Janssen”) involving Invokana (canagliflozin) to In re: Invokana (Canagliflozin) Products 

Liability Litigation, MDL No. 2750 (“MDL 2750”). 

WHEREAS, the Parties have agreed this stipulation will further judicial economy, and allow 

the Parties to efficiently pursue pleadings, motions, and discovery once the appropriate course of 

action is determined by the JPML. 

WHEREAS, the Parties request the Court to stay all proceedings in this action, including, but 

not limited to the filing of a stipulation/proposed order or motion for the filing of an amended 

complaint and the scheduled Status (Pretrial Scheduling) Conference set for January 5, 2017 at 2:30 

PM in Courtroom 3 before District Judge Kimberly J. Mueller with the filing of a joint status report 

due seven days prior, pending the resolution of the pending motion by the JPML. 

The Parties hereby STIPULATE this case be stayed pending the JPML’s ruling on the pending 

motion. 

Dated: October 11, 2016 Respectfully Submitted 

Case 2:15-cv-02217-KJM-EFB Document 29 Filed 10/17/16 Page 2 of 3
CERTIFICATE OF SERVICE 

1195130.1 

 

 By: /s/ Michael B. Lynch

 Michael B. Lynch (SBN 21914) 

THE MICHAEL BRADY LYNCH FIRM

127 West Fairbanks Ave., Ste. 528 

Winter Park, FL 32789 

Tel: (877) 513-9517 

Fax: (321) 972-3568 

michael@mblynchfirm.com

Michael Louis Kelly 

Behram V. Parekh 

Ruth Rizkalla 

By: /s/ Behram V. Parekh 

Behram V. Parekh (SBN 180361) 

bvp@kirtlandpackard.com 

KIRTLAND & PACKARD LLP 

2041 Rosecrans Avenue, Third Floor 

El Segundo, California 90245 

Telephone: (310) 536-1000 

Facsimile: (310) 536-1001 

Counsel for Plaintiffs 

By: /s/ Mollie F. Benedict 

TUCKER ELLIS LLP

515 South Flower Street 

Forty-Second Floor 

Los Angeles, CA 90071-2223 

Tel: 213.430.3400; Fax: 213.430.3409 

Counsel for Defendants Janssen Research & 

Development, LLC, Janssen Pharmaceuticals, 

Inc. and Johnson & Johnson 

IT IS SO ORDERED. 

Dated: October 14, 2016. 

Case 2:15-cv-02217-KJM-EFB Document 29 Filed 10/17/16 Page 3 of 3